OpenAI 收购 Orchestra Bio，并入 Rosalind 生命科学模型体系
摘要
OpenAI 宣布收购 Orchestra Bio，后者是帮助生物制药团队协调药物开发复杂流程的平台。OpenAI 表示将基于其面向生命科学研究的 Rosalind 模型与工具继续建设，以简化这些运营流程，并欢迎 @ashokaraj_ 及团队加入。转发该消息的 TestingCatalog 认为，生命科学领域的 AI 进展是 Anthropic、OpenAI 和 Google 当前的重点方向之一。
摘要由模型根据原文撰写，以原文为准。
正文 · 原文
OpenAI ❤️ Orchestra Bio
OpenAI has acquired Orchestra Bio to work on Rosalind models and tools for life sciences research.
"Orchestra Bio is a platform that helps biopharma teams coordinate the complex process of drug development."
AI advancements in life sciences are probably one of the most desired areas for many. So far, it seems like a top priority for Anthropic, OpenAI, and Google.
We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development. Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner. Welcome @ashokaraj_ and team! https://openai.com/index/openai-to-acquire-orchestra-bio/在 X 查看被引用的帖子
来源：🚨 AI News | TestingCatalog · x.com
引用原文
testingcatalog. OpenAI ❤️ Orchestra Bio[EB/OL]. (2026-10-21)[访问日期]. https://x.com/testingcatalog/status/2112610230043312618.